2022 / 01

Next Paper
DOI: 10.47183/mes.2022.004

CLINICAL CASE

Focal laser photocoagulation of the optic disc peripapillary neovascularization in patient with proliferative diabetic retinopathy

Takhchidi KhP, Takhchidi NKh, Kasmynina TA, Tebina EP
About authors

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Ekaterina P. Tebina
Volokolamskoe shosse, 30, korp. 2, Moscow, 123182, Russia; ur.liam@anibetaniretake

About paper

Author contribution: Takhchidi KhP — study concept and design, manuscript editing; Takhchidi NKh — literature analysis; Tebina EP — data acquisition and processing, manuscript writing; Kasminina TA — laser therapy.

Compliance with ethical standards: the patient submitted the informed consent to laser therapy and personal data processing.

Received: 2022-01-15 Accepted: 2022-03-01 Published online: 2022-03-13
|
  1. Stewart MW.Treatment of diabetic retinopathy: Recent advances and unresolved challenges. World J Diabetes. 2016; 7 (16): 333–341.
  2. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009; 116 (3): 497–503.
  3. Sergushev SG, Homjakova EN. Anti-VEGF preparaty v terapii pacientov s diabeticheskim makuljarnym otekom. Klinicheskaja oftal'mologija. 2019; 25 (4): 238–44. Russian.
  4. Federal'nyi registr saharnogo diabeta RF, realizuemyĭ FGBU «NMIC ̆ jendokrinologii» Minzdrava Rossii. Dostupno po ssylke: https:// www. endocrincentr.ru/sites/default/files/all/EVENTS2019/ NEWS%20SUM/13.03.19%20Prof.komissia/VIK_Exp_13.03.19. pdf.
  5. Smirnova OM. Diabeticheskaja retinopatija. Rezul'taty mezhdunarodnyh mnogocentrovyh issledovanij. Saharnyj diabet. 2010; 13 (1): 80–87. Russian.
  6. Bosma EK, van Noorden CJF, Klaassen I, Schlingemann RO. Diabetic Nephropathy. Springer, 2019. DOI: 10.1007/978-3-31993521-8_19.
  7. Burjakov DA, Kachalina GF, Pedanova EK, Kryl LA. Ocenka bezopasnosti povtornyh seansov subporogovogo mikroimpul'snogo lazernogo vozdeistvija pri lechenii diabeticheskogo makuljarnogo ̆ oteka. Sovremennye tehnologii v oftal'mologii. 2015; 3: 19–21. ̈ Russian.
  8. Zajka VA, Shhuko AG, Arhipov EV, Bukina VV. Ocenka dolgosrochnoj jeffektivnosti panretinal'noj lazernoj koaguljacii pri saharnom diabete 2-go tipa. Sovremennye tehnologii v oftal'mologii. 2020; (1): 34–36. Russian.
  9. Gacu MV, Bajborodov YaV. Kliniko-topograficheskaja klassifikacija diabeticheskih makulopatij. Saharnyj diabet. 2008; 11 (3): 20–22. Russian.
  10. Jacob T. Cox, Dean Eliott, and Lucia Sobrin. Inflammatory Complications of Intravitreal Anti-VEGF Injections. J Clin Med. 2021; 10 (5): 981.
  11. Yau JW, et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; (35): 556–64.